ADVBAdvanced Biomed Inc.
Health Care
Operating Expenses revised down 64.0% for FY 2025
This is the 8th largest revision in ADVB's history.
Operating Expenses·FY 2025
Major restatement$1.1M▼ 64.0%
was$3M
Revised down in a 10-K.
Verify against SEC filingsShow
As reported$3M
Accepted 2025-10-090001213900-25-097465
Restated$1.1M
Accepted 2026-10-140001213900-26-109029
OperatingExpenses · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time ADVB — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.